zeleciment basivarsen (DYNE-101)
DYNE101-DM1-301
Phase 3 small_molecule active
Quick answer
zeleciment basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) is a Phase 3 program (small_molecule) at Dyne Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dyne Therapeutics
- Indication
- Myotonic Dystrophy Type 1 (DM1)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active